New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 4, 2012
12:20 EDTRGLSRegulus Therapeutics to present new data on miR-21 at Kidney Week
Regulus Therapeutics announced that new preclinical data targeting microRNA-21, miR-21, will be presented at 10:00 a.m. PDT on November 3 in a late-breaking poster session at the American Society of Nephrology's Kidney Week 2012, meeting in San Diego, CA, October 30óNovember 4.
News For RGLS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 26, 2015
15:27 EDTRGLSRegulus reports 'impressive' data on RG-101 for the treatment of HCV
Subscribe for More Information
April 21, 2015
07:44 EDTRGLSRegulus resumed with an Outperform at FBR Capital
Subscribe for More Information
06:14 EDTRGLSRegulus coverage resumed with an Outperform at FBR Capital
Target $30.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use